51 results
6-K
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
11 Jun 24
Current report (foreign)
4:30pm
, responsible for running operations and development of the Company. Prior to joining the Company, from March 2021 to August 2023, Dr. McCracken served
6-K
EX-10.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
22 Jan 24
Current report (foreign)
5:28pm
the Manager be responsible for any amount in excess of the Broker Fee applicable to the Shares and paid hereunder. This indemnity agreement … party in any action for which indemnification is sought (in which case the indemnifying party shall not thereafter be responsible for the fees
424B5
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
22 Jan 24
Prospectus supplement for primary offering
5:27pm
Act Liabilities
We are responsible for the information contained and incorporated by reference in this prospectus, in any accompanying prospectus
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
12 Jan 24
Current report (foreign)
7:43am
and wellness mobile application developer. The chief operating decision maker is responsible for allocating resources and assessing performance
UPLOAD
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
12 Dec 23
Letter from SEC
12:00am
are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of
action by the staff
F-3
qgo4fto0w ypbvyae
5 Dec 23
Shelf registration (foreign)
4:06pm
6-K
EX-99.3
yllrsox4qkcac4rf2f4
8 Nov 23
Current report (foreign)
4:11pm
6-K
EX-4.1
h6r34amplqg9yk3
12 Oct 23
Current report (foreign)
8:00am
6-K
EX-10.1
9ztvaw
1 Sep 23
Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum
7:37am
6-K
EX-99.1
vzyt3w zs
14 Jun 23
Virax Biolabs' CEO James Foster Issues Letter to Shareholders
8:00am
424B3
e623jc2b
2 Dec 22
Prospectus supplement
4:17pm
UPLOAD
tfj 5c7g3cw8vl4a2
25 Nov 22
Letter from SEC
12:00am
F-1
3l2oz
18 Nov 22
Registration statement (foreign)
5:39pm
6-K
EX-10.1
bxinisjdgmob8k9wte
18 Nov 22
Current report (foreign)
5:20pm
6-K
EX-10.3
lfe65 zyvu7sm565j
8 Nov 22
Virax Biolabs Group Limited Announces $3.8 Million Private Placement
4:56pm
6-K
EX-10.4
pk3mc7 6d
8 Nov 22
Virax Biolabs Group Limited Announces $3.8 Million Private Placement
4:56pm